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Abstract Article Info 
Introduction: Nasopharyngeal carcinoma (NPC) is a head and neck malignancy that is endemic in Southern 
China and Southeast Asia, including Indonesia. Currently, the TNM classification based on anatomical 
information is the most commonly used staging system. However, large variations were reported in clinical 
outcomes from one patient to another, even though they were at the same stage and had the same management 
strategy. MPV is an indicator of increased platelet activation and can easily be detected from peripheral blood 
through complete blood count analysis. MPV can be used as a marker of angiogenesis in patients with 
malignancy because of the role of platelets as angiogenic, metastatic and proteolytic in the inflammatory process 
of malignancy. 
Objective: To investigate the Mean Platelet Volume (MPV) profile in Nasopharyngeal Carcinoma patients 
before undergoing therapy at Sanglah General Hospital, Denpasar. 
Methods: This study was a cross-sectional descriptive study with 77 samples from April to June 2020 by 
performing a complete blood count in patients who had recently been diagnosed with nasopharyngeal carcinoma 
and had never undergone other treatment related to malignancy such as radiotherapy and chemotherapy. 
Results: The MPV value increased the most in male group compared to the female group (87.5% : 71.4%). MPV 
value is also have increased the most in the age group >50 years compared to other age groups (83.6%). Clinical 
stage IV is known to have increased the MPV value the most compared to other clinical stage groups (100%). 
There was an increase in the MPV value most in the histopathological type group of NKSCC compared to the 
other histopathological type groups (83.7%). 
Conclusion: The MPV value most increased in the male group, the age group >50 years, clinical stage IV group, 
and the histopathological type group of NKSCC. 
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Every year, malignant cancer in the head and neck area is diagnosed 
worldwide and is the 8th most common malignancy [1]. Nasopharyngeal 
carcinoma (NPC) is a head and neck malignancy that is endemic in Southern 
China and Southeast Asia, including Indonesia with an incidence of 50 cases 
per 100,000 population and a low survival rate [2]. 
Currently, the TNM classification (T=tumor size, N=regional 
node/lymph node, M=metastasis) from the American Joint Committee 
on Cancer (AJCC) based on anatomical information is the most 
commonly used staging system. However, large variations were 
reported in clinical outcomes from one patient to another, even though 
they were at the same stage and had the same management strategy. 
These findings indicate that the staging system is still insufficient to 
predict recurrence and does not reflect the biological heterogeneity of 
NPC patients. Although several studies have identified specific 
survival-related biomarkers, they are less robust and nearly unusable 
clinically. Thus, it is important to identify biomarkers that are effective 
and readily available for the prognosis of patients with malignancy [3].  
Thrombosis analysis which includes platelet count, Mean Platelet Volume 
(MPV), Platelet Distribution Width (PDW) has been carried out effectively [4]. 
MPV is an indicator of increased platelet activation and can easily be detected 
from peripheral blood through complete blood count analysis [4]. 
Measuring the MPV value is a simple test, cheap, useful, easy to 
apply, without additional costs. In addition, MPV provides information 
on platelet function and diameter, as well as a good indicator of platelet 
activation. A high MPV value indicates the presence of large and active 
platelets in peripheral blood vessels. In the literature, MPV is reported 
as a prognostic factor for several types of cancer, including head and 
neck malignancies [5]. 
MPV can be used as a marker of angiogenesis in patients with 
malignancy because of the role of platelets as angiogenic, metastatic and 
proteolytic in the inflammatory process of malignancy. Tumor cells release 
procoagulants, fibrinolytic factors, mediators, proteases, cytokines, which 
have a direct influence on platelet production and activation and directly 
interact with thrombosis via adhesion molecules [6]. 
Several reports have shown that increased MPV values are associated 
with the prognosis of various cancers. Cho et al., (2013) reported that 
patients with hepatocellular carcinoma had a higher MPV value than the 
control group. In addition, Kemal et al., (2014) found that patients with 
epithelial ovarian cancer had a significant increase in MPV values compared 
to the control group. Osada et al., (2010) also found that patients with gastric 
cancer had a higher MPV value than the control group [7]. 
2. MATERIALS AND METHODS 
This study was a cross-sectional descriptive study by performing a 
complete blood count in patients who had recently been diagnosed with 
nasopharyngeal carcinoma and had never undergone other treatment 
related to malignancy such as radiotherapy and chemotherapy. The 
research was carried out from April 2020 to June 2020 at ENT-HNS 
clinic and Clinical Pathology Laboratory of Sanglah Hospital, 
Denpasar. This study uses consecutive sampling with 77 samples. 
Patients who were newly diagnosed with nasopharyngeal 
carcinoma were staged to determine the clinical stage of the patient. 
Patients who have been erect with nasopharyngeal carcinoma at a 
certain stage were then asked for consent to be the study sample. 
Patients who were willing to be the study sample, then performed a 
complete blood count at the clinical pathology laboratory of Sanglah 
General Hospital Denpasar. Histopathological type, clinical stage and 
MPV data were collected in a data collection sheet. Data processing was 







done by descriptive method. The data is presented in the form of tables, 
graphs and narratives to display the characteristics of the sample and 
the MPV profile of the sample.  
3. RESULTS 
Table 1. Characteristics of NPC Patients based on Sex  







Total 77 100 
 Based on sex, the distribution of NPC patients as seen in Table 1, shows 
that the largest sex group of NPC patients was male, 56 samples (72.7%). 
While the female group was 21 samples (27.3%). 
Table 2. Characteristics of NPC Patients based on Age 
Age n % 
<20 years old 
20-29 years old 
30-39 years old 
40-49 years old 











Total 77 100 
Based on age, the distribution of NPC patients as seen in Table 2 shows 
that the largest age group of NPC patients is >50 years, 43 samples (55.8%), 
followed by the 40-49 age group of 27 samples (35.1%), age group 30-39 
years as many as 7 people (9.1%). Meanwhile, patients with 20-29 years and 
age group <20 years were no samples. 
Table 3. Characteristics of NPC Patients based on Clinical Staging 













Total 77 100 
Based on the clinical stage, the distribution of NPC patients as seen in 
Table 3 shows that the most clinical stage group of NPC patients was stage 
IV as many as 34 people (44.2%), followed by the stage III group with 32 
people (41.6%), the stage II group as many as 11 people (14.3%). While the 
stage I group was not found. 
Table 4. Characteristics of NPC Patients based on Histopathological Type 
Histopathological type n     % 
Keratinizing Squamous Cell Ca 








Total 77 100 
Based on the type of histopathology, the distribution of NPC patients as 
seen in Table 4 shows that the most histopathologic type group of NPC 
patients is non keratinizing squamous cell carcinoma as many as 43 samples 
(55.8%), followed by the histopathology group of undifferentiated 
carcinomas as many as 34 samples (44.2%). Meanwhile, the 
histopathological group of keratinizing squamous cell carcinoma was not 
found. 
Further statistical analysis was conducted to determine the distribution 
of MPV values in NPC patients who were treated at the ENT-HNS clinic at 
Sanglah Hospital Denpasar according to the research variables presented in 
Graphic 1 and Table 5 below. Based on Graphic 1, the distribution of MPV 
values is mostly found in the range 10.0-12.0 fl with a mean value of 
10.68±1.32. 
 
Graphic 1. Distribution of MPV Value in NPC Patients 
Table 5. Characteristics of Increase and Decrease in MPV Value in NPC 
Patients from Normal Value 






























































































Based on data analysis as shown in Table 5, it was found that in the 
male group, the MPV value increased the most compared to the female sex 
group. MPV value is also known to have increased the most in the age group 
>50 years compared to other age groups. Clinical stage IV is known to have 
increased the MPV value the most compared to other clinical stage groups. 
There was an increase in the MPV value most in the histopathological type 
group of NKSCC compared to the other histopathological type groups. 
4. DISCUSSION 
NPC is a head and neck malignancy that is endemic in southern China 
and Southeast Asia with an incidence of 50 cases per 100,000 population 
and a low survival rate for patients. In this study it was found that the sex of 
NPC patients with the highest frequency was male as many as 56 samples 
(72.3%). This result is in accordance with previous research conducted in 
Medan [8]. Several studies in various countries also show that there are more 
male NPC patients than women with an average ratio of 2–3:1.35 NPC 
patients are more common in male than female were reported in almost all 
studies, this is thought to be related to life and work habits that cause men 
to be frequently exposed to carcinogens that cause NPC. Workplace 
exposure to vapors, dust fumes and chemical gases increases the risk of NPC 
2-6 times, while exposure to formaldehyde increases the risk 2-4 times. 
In this study it was also seen that the age distribution of NPC patients 
with the highest frequency was >50 years as many as 43 people (55.8%), 
while in the age group 20-29 years and <20 years were not found. Although 
not exactly the same, it is in line with other researchers who get the most 







NPC patients in the 36–60 year age group [8]. Hasibuan, et al. also found 
that the most age group of NPC patients was the 41-60 years group. This is 
because the DNA repair mechanism that has mutated (DNA repair) is not 
functioning properly and the body's immune system is decreased at the age 
of more than 40 years, so that patients with malignancy are more likely to 
occur in the elderly [9]. 
In this study it was also found that the distribution of clinical stage of 
NPC patients with the highest frequency was stage IV with 34 people 
(44.2%), while the lowest frequency was found in the stage I group of 0 
people (0%) [9]. Early symptoms of NPC are not typical, similar to an upper 
respiratory tract infection so that they receive less attention from the patient 
and the examining doctor. In addition, the location of the tumor hidden in 
the nasopharynx so that it is difficult to examine, inadequate equipment, 
inadequate knowledge, trust in non-medical treatment, fear of seeing a 
doctor and the weak socioeconomic condition of the patients are often 
obstacles in making a diagnosis of this disease. Therefore, early symptoms 
of NPC are often missed and patients are diagnosed after the size of the 
tumor and enlarged lymph nodes are large at an advanced stage so that 
patients often come for treatment when they are at an advanced stage [9]. 
In this study, it was found that the distribution of histopathological types 
of NPC patients with the highest frequency was non keratinizing squamous 
cell carcinoma as many as 43 people (55.8%), while the lowest frequency 
was found in the histopathology group of keratinizing squamous cell 
carcinoma as many as 0 people (0%). This finding is the same as several 
studies which found that the proportion of histopathological types of 
NKSCC and undifferentiated carcinoma was mostly found, especially in 
endemic areas. Meanwhile, KSCC tends to be higher in NPC patients in 
non-endemic areas. Several studies reported that KSCC has an incidence 
rate of 25% in NPC patients in North America, but only around 1% in 
endemic areas, while NKSCC and undifferentiated carcinoma account for 
95% of cases in high incidence areas, but around 60% in North America 
[10]. The incidence of NKSCC and undifferentiated carcinoma is also high 
in the Eskimo region, Alaska and there is also an increasing incidence in 
Malaysia, North Africa and Southern Europe [11]. As is known, the 
keratinizing type is an invasive type that has the worst prognosis because it 
is not radioresponsive and according to research, tobacco and alcohol play 
a role in its relationship to the histopathological type of keratinizing. 
Meanwhile, the NKSCC and undifferentiated types had a strong correlation 
with the predominant incidence rate at younger ages and were associated 
with an increase in anti-EBV antibody titers, indicating the role of the EBV 
virus in both types of histopathology [12]. 
In this study, it was proven that the MPV value in NPC patients was found 
to be higher in the male group of 49 (87.5%) patients compared to the female 
group. The prevalence of NPC tends to be more prevalent in males than 
females in relation to the pattern and lifestyle as well as environmental factors 
towards carcinogenic exposure which is more dominant in males [13]. 
In this study it was proven that the MPV value in NPC patients was 
found to be the most increased in the age group >50 years of 36 (83.6%) 
patients. Verdoia, et al. found that advancing age was directly related to 
greater mean platelet volume, but did not contribute to explaining the higher 
prevalence and rates of coronary artery disease in elderly patients [14]. 
In this study it was proven that the mean MPV value in NPC patients 
was found to be the most increased in stage IV of 34 (100%) patients. 
Sehitoglu, et al. reported that increasing the MPV value is not only important 
in the process of invasion and recurrence of Kaposi's sarcoma, but also 
important for response to therapy. They reported an increase in the MPV 
value in Kaposi sarcoma patients and the MPV value increased according to 
the stage, as well as a higher MPV value in relapsed Kaposi sarcoma patients 
[15]. In addition, Keles, et al. in his study of 104 renal cell carcinoma 
patients, he found an increase in the mean MPV value along with the higher 
stage of kidney cancer, where the lowest MPV mean value was found at 
stage I and the highest was at stage IV [16]. 
Evidence of the relationship between high MPV and advanced cancer 
is also emerging, such as colon cancer, blood cancer, kidney cancer, liver 
cancer, gastric cancer, and endometrial cancer. The underlying mechanism 
is also very clear, whereby the platelet activation process, which is 
stimulated by inflammatory factors such as interleukin-6, tends to produce 
platelets with massive and giant characteristics. Therefore, it can be 
expected that the number and volume of platelets will increase compared to 
more benign disease conditions [3]. 
In this study it was proven that the mean MPV value in NPC patients 
was found to be the most increased in the histopathological type of NKSCC, 
amounting to 36 (86.7%) patients. Zhang, et al. (2016) in their research 
suggests that the dominant histopathological type of esophageal carcinoma 
in some patients in China is squamous cell carcinoma, which accounts for 
90% of all cases. Despite advances in radical resection and 
radiochemotherapy, the survival rate for people with esophageal carcinoma 
with squamous cell type is still low (only <30% can survive 5 years). In that 
study, MPV was used as a platelet activation scoring system to evaluate the 
prognosis of cancer patients, they evaluated the relationship between several 
clinical variables and overall survival and disease-free survival where it was 
found that MPV had the best discriminatory ability as lymph node 
metastasis status. The study proved that MPV biomarkers had prognostic 
value in 468 esophageal carcinoma patients with histopathological 
squamous cell type compared to undifferentiated type. Research in Korea 
revealed that the group of liver cancer patients with stratified squamous cell 
types had higher MPV levels than the normal control group.3 However, until 
now, there is still no literature explaining how the pathophysiological 
mechanism associated with increased MPV levels on the histopathological 
type of NKSCC. 
Epithelial-mesenchymal transitions, or mesenchymal-epithelial 
transitions, play an important role in increased migration capacity, increased 
invasion capacity, increased resistance to apoptosis and increased 
production of extracellular matrix components. Lou, et al. showed the 
expression of epithelial-mesenchymal transition-related proteins, such as E-
cadherin, cytokeratin (CK), vimentin and Ncadherin. Tumor cell-induced 
platelet aggregation triggers platelets to release alpha granules, which 
contain TGF-β and platelet-derived growth factor (PDGF) at concentrations 
several times higher than most cell types. Platelet-derived TGF-β activates 
the Smad signaling pathway and the trans-differentiation of circulating 
tumor cells into mesenchymal-like phenotypes. PDGF is a motor of 
epithelial transition that contributes to cancer invasion and angiogenesis. In 
addition, TGF-β was shown to increase the expression of PDGF and PDGF 
receptors through β catenin activation and signal transducer and activator of 
transcription 3 (STAT3) [17].  
5. CONCLUSION 
This study found that the MPV value most increased in the male group, 
the age group >50 years, clinical stage IV group, and the histopathological 
type group of NKSCC.  
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